Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Estimating the Risk for and Severity of Respiratory Infections Attributable to CFTR Heterozygosity

NCT05474430 is registered in ClinicalTrials.gov with Philip Polgreen as lead sponsor.

NCT NCT05474430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05474430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Estimating the Risk for and Severity of Respiratory Infections Attributable to CFTR Heterozygosity
Lead sponsor
Philip Polgreen
Phase
Observational
Overall status
Recruiting
Start date
December 20, 2021
Completion date
December 31, 2026
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carrier state, respiratory infections